unknown
Stage
About
Biotia develops genomics-based diagnostic tools and platforms that detect and characterize pathogens. The company leverages metagenomics and AI to improve infectious disease diagnostics, support outbreak prediction, and enable global health monitoring.
Explore Biotia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.